Racial Differences in Treatment of Early-Stage Prostate Cancer

Urology

Volumn 71, Issue 6, 2008, Pages 1172-1176

  Richert Boe, Kathryn E ^a   Weinmann, Sheila ^a   Shapiro, Jean A ^b   Rybicki, Benjamin A ^c   Enger, Shelley M ^d   Van Den Eeden, Stephen K ^e   Weiss, Noel S ^f  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d KAISER PERMANENTE   (United States)

^e Kaiser Permanente ^*  (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; HEALTH CARE ACCESS; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL INFORMATION; MEDICAL RECORD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; TREATMENT REFUSAL;

ADULT; AFRICAN AMERICANS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 44649142212     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.10.010     Document Type: Article

References (14)

1. Nelson W.G., De Marzo A.M., and Issacs W.B. Prostate cancer. N Eng J Med 349 (2003) 366-381
2. Hoffman R.M., Harlan L.C., Klabunde C.N., et al. Racial differences in initial treatment for clinically localized prostate cancer. Results from the Prostate Cancer Outcomes Study. J Gen Int Med 18 (2003) 845-853
3. Godley P.A., Schenck A.P., Amamoo M.A., et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst 95 (2003) 1702-1710
4. Fowler Jr. J.E., Bigler S.A., Bowman G., et al. Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment. J Urol 163 (2000) 137-142
5. Klabunde C.N., Potosky A.L., Harlan L.C., et al. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care 36 (1988) 1337-1348
6. Optenberg S.A., Thompson I.M., Friedrichs P., et al. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA 274 (1995) 1599-1605
7. Fishman P.A., Goodman M.J., Hornbrook M.C., et al. Risk adjustment using automated ambulatory pharmacy data: the RxRisk Model. Med Care 41 (2003) 84-99
8. Meenan R.T., Goodman M.J., Fishman P.A., et al. Risk-adjustment models to identify high-cost risks. Med Care 41 (2003) 1301-1312
9. Charlson M.E., Pompei P., Ale K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40 (1987) 373-383
10. Denberg T.D., Beaty B.L., Kim F.J., et al. Marriage and ethnicity predict treatment in localized prostate carcinoma. Cancer 103 (2005) 1819-1825
11. Zeliadt S.B., Potosky A.L., Etzioni R., et al. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urol 64 (2004) 1171-1176
12. Underwood III W., Jackson J., Wei J.T., et al. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer 103 (2005) 538-545
13. Steginga S.K., Occhipinti S., Gardiner R.A., et al. Making decisions about treatment for localized prostate cancer. BJU Int 89 (2002) 255-260
14. Zeliadt S.B., Ramsey S.D., Penson D.F., et al. Why do men choose one treatment over another?. A review of patient decision making for localized prostate cancer. Cancer 106 (2006) 1865-1874